Roche to fight for Avastin as breast cancer drug (Reuters)
Reuters – WASHINGTON (Reuters) — Drugmaker Roche Holding AG will try to convince U. S. regulators to reverse course on Avastin, the world’s best-selling cancer medicine, and approve its use for breast cancer in a hearing this week.
View full post on Yahoo! News: Health News
Leave a Reply